SCHEMBL7218762

SCHEMBL7218762

OCCCC(O)c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.65
KCNH2 Q12809 8/20 0.64
CYP3A4 P08684 5/20 0.54
ADORA2A P29274 6/20 0.54
ADORA1 P30542 6/20 0.54
ADORA3 P0DMS8 2/20 0.54
HTT P42858 2/20 0.54
ADORA2B P29275 1/20 0.54
CYP2C19 P33261 1/20 0.54
ABCG2 Q9UNQ0 1/20 0.54
KDM4E B2RXH2 1/20 0.54
NR1I2 O75469 1/20 0.54
LMNA P02545 1/20 0.54
TP53 P04637 1/20 0.54
CYP1A2 P05177 1/20 0.54
HTR1A P08908 1/20 0.54
TSHR P16473 1/20 0.54
CNR1 P21554 1/20 0.54
GLRA1 P23415 1/20 0.54
SLC6A2 P23975 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7227252 0.96 CYP2D6 (0.64) CYP2D6KCNH2CYP3A4ADORA2AADORA1
SCHEMBL11928628 0.88 KCNH2 (0.65) CYP2D6KCNH2CYP3A4ADORA2AADORA1
SCHEMBL11904470 0.88 KCNH2 (0.65) CYP2D6KCNH2CYP3A4ADORA2AADORA1
SCHEMBL11904082 0.88 KCNH2 (0.65) CYP2D6KCNH2CYP3A4ADORA2AADORA1
SCHEMBL18343581 0.88 KCNH2 (0.77) CYP2D6KCNH2CYP3A4ADORA2AADORA1
SCHEMBL8554946 0.86 KCNH2 (0.65) CYP2D6KCNH2CYP3A4ADORA2AADORA1
SCHEMBL7813442 0.85 CYP2D6 (0.66) CYP2D6KCNH2CYP3A4ADORA2AADORA1
SCHEMBL11929028 0.85 CYP2D6 (0.62) CYP2D6KCNH2CYP3A4ADORA2AADORA1
SCHEMBL18343551 0.83 KCNH2 (0.78) CYP2D6KCNH2CYP3A4ADORA2AADORA1
SCHEMBL18343530 0.83 CYP2D6 (0.90) CYP2D6KCNH2CYP3A4ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583156-B1 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol VERNALIS RESEARCH LIMITED (GB) 2003-06-24 US disclosed
EP-1107760-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (I) VERNALIS RESEARCH LIMITED (GB) 2001-06-20 EP disclosed
WO-2000013681-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (I) VERNALIS RESEARCH LIMITED (GB) 2000-03-16 WO disclosed